PD-L2 expression in colorectal cancer: Independent prognostic effect and targetability by deglycosylation

Colorectal cancer (CRC) is the second leading cause of cancer death worldwide, and immune checkpoint blockade therapy provides an opportunity for improving the outcome of CRC patients. Recent studies suggest that programmed death ligand-1 (PD-L1) is only expressed in 12% of CRCs. Here, we demonstrat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Wang, Huanbin, Yao, Han, Li, Chushu, Liang, Lunxi, Zhang, Yao, Shi, Hubing, Zhou, Chongzhi, Chen, Yingxuan, Fang, Jing-Yuan, Xu, Jie
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5543903/
https://ncbi.nlm.nih.gov/pubmed/28811964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1327494
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados